Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the effectiveness of self-administered perioperative guided imagery to reduce perioperative distress in gynecologic oncology patients undergoing surgical management for a presumed cancer diagnosis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Guided Imagery Guided Imagery With Audio Media |
Behavioral: Guided Imagery With Audio Media
Subjects assigned to the experimental arm will be asked to participate in meditation daily using the audio media provided for the 7 days prior to surgery, in the preoperative holding area, for the 7 days following surgery, and are encouraged to engage in affirmations module use at least weekly in the 6-8 week postoperative period.
|
No Intervention: Routine Postoperative Care Subjects will receive routine pre-operative, intra-operative, post-operative, chemotherapy, and radiation care as dictated by pathologic diagnosis. |
Outcome Measures
Primary Outcome Measures
- Level of distress in the immediate postoperative period, measured by the numeric rating scale/ National Comprehensive Cancer Network (NCCN) Distress Thermometer screening instrument. [postoperative day 1]
- Level of distress in the delayed postoperative period, measured by the numeric rating scale/ National Comprehensive Cancer Network (NCCN) Distress Thermometer screening instrument. [6-8 week postoperative exam]
Secondary Outcome Measures
- Level of distress, measured by questionnaire using the Hospital Anxiety and Depression Scale-total (HADS-T). [postoperative day 1 and 6-8 week postoperative exam]
- Level of anxiety and depressions, measured by questionnaire using the Hospital Anxiety and Depression Scale subscale for anxiety (HADS-A) and depression (HADS-D). [postoperative day 1 and 6-8 week postoperative exam]
- Level of pain, measured by a 7-item questionnaire using a Likert numerical rating scale for pain [postoperative day 1 and 6-8 week postoperative exam]
- Perioperative analgesic use, measured by patient-completed usage log and hospital medical record. [postoperative day 1 and 6-8 week postoperative exam]
- Patient satisfaction regarding in hospital perioperative care, measured by a questionnaire adapted from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey. [postoperative day 1 and 6-8 week postoperative exam]
- Effect of perioperative guided imagery on health care compliance, measured by the General Adherence Scale (GAS) survey. [6-8 week postoperative visit]
- Effect of perioperative guided imagery on health care related locus of control, measured by the Multidimensional Health Locus of Control-form A (MHLC-A) questionnaire. [postoperative day 1 and 6-8 week postoperative exam]
- The effect of perioperative guided imagery on hope, measured by the Adult Hope Scale (AHS) questionnaire. [postoperative day 1 and 6-8 week postoperative exam]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Undergoing surgical management for a suspected diagnosis of Gynecologic Malignancy (Endometrial, Ovarian, Vulvar, Vaginal, Primary Peritoneal, Fallopian Tube)
-
Age 18 or greater
-
Receiving care at University of Michigan Comprehensive Cancer Center Gynecologic Oncology Clinic or at St. Joseph Mercy Hospital, Alexander Cancer Care Center
-
Able to understand and read English
-
Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
-
Patients must have working telephone, mobile or land line
Exclusion Criteria:
-
Severe hearing impairment that limits the ability to use audio-based guided imagery modules
-
Current documented alcohol abuse or illicit drug substance abuse
-
Planned outpatient surgery
-
Patients currently participating in a meditation practice for more than 1 hour per week prior to preoperative visit.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Michigan Cancer Center | Ann Arbor | Michigan | United States | 48109 |
Sponsors and Collaborators
- University of Michigan
Investigators
- Principal Investigator: Brandy Michaels, MD, University of Michigan
- Principal Investigator: J. Rebecca Liu, MD, University of Michigan
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HUM00095520